Sulfonamido-macrocycles as Tie2 inhibitors

Details for Australian Patent Application No. 2005318361 (hide)

Owner Bayer Schering Pharma Aktiengesellschaft

Inventors Husemann, Manfred; Luecking, Ulrich; Schwede, Wolfgang; Kettschau, Georg; Huth, Andreas; Schaefer, Martina; Briem, Hans; Thierauch, Karl-Heinz

Agent Davies Collison Cave

Pub. Number AU-A-2005318361

PCT Pub. Number WO2006/066957

Priority 04090509.3 22.12.04 EP

Filing date 19 December 2005

Wipo publication date 29 June 2006

International Classifications

C07D 513/08 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

A61K 31/529 (2006.01) - forming part of bridged ring systems

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

19 July 2007 PCT application entered the National Phase

  PCT publication WO2006/066957 Priority application(s): WO2006/066957

14 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005318365-Solid pharmaceutical composition comprising valsartan

2005318360-Sulfonamido-macrocycles as TIE2 inhibitors